Stocks and Investing
Stocks and Investing
Wed, December 6, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, December 5, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Reni Benjamin Reiterated (BCAB) at Buy and Held Target at $12 on, Dec 5th, 2023
Reni Benjamin of JMP Securities, Reiterated "BioAtla, Inc." (BCAB) at Buy and Held Target at $12 on, Dec 5th, 2023.
Reni has made no other calls on BCAB in the last 4 months.
There are 2 other peers that have a rating on BCAB. Out of the 2 peers that are also analyzing BCAB, 0 agree with Reni's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Reni
- Arthur He of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, November 8th, 2023
- Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $14 on, Monday, September 25th, 2023
Contributing Sources